Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
APA
Huff AL, Haldar SD, et al. (2026). Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.. Nature communications, 17(1). https://doi.org/10.1038/s41467-026-71968-x
MLA
Huff AL, et al.. "Publisher Correction: Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.." Nature communications, vol. 17, no. 1, 2026.
PMID
41986375